The initial serum levels of CXCL10 were significantly higher in patients with distal CCA compared to other tumor localizations (Figure S2A) but were unaltered between patients with different TNM stages, tumor grading or resection status (Figure S2B–F). Here, CXCL10 is linked to neoplasm.